Kremers, B. M. M.; Posma, J. N.; Heitmeier, S. et al.
Discovery of four plasmatic biomarkers potentially predicting cardiovascular outcome in peripheral artery diseaseSCIENTIFIC REPORTS. Bd. 12. H. 1. 2022
Masoodi, Mojgan; Peschka, Manuela; Schmiedel, Stefan et al.
Disturbed lipid and amino acid metabolisms in COVID-19 patientsJOURNAL OF MOLECULAR MEDICINE-JMM. Bd. 100. H. 4. 2022 S. 555-568
Wiedenroth, Christoph B.; Bandorski, Dirk; Ariobi, Kanischka et al.
Does Age Matter? Pulmonary Endarterectomy in the Elderly Patient with CTEPHTHORACIC AND CARDIOVASCULAR SURGEON. Bd. 70. H. 08. 2022 S. 663-670
Sanchez, Olivier; Konstantinides, ?
Does Fibrinolytic Strategy of Pulmonary Embolism International ThrOmbolysis PEITHO-3 Trial Need More Strong EvidenceTHROMBOSIS AND HAEMOSTASIS. Bd. 122. H. 12. 2022 S. 2052-2053
Willems, Loes H.; Thijssen, Dick H. J.; Groh, Laszlo A. et al.
Dual pathway inhibition as compared to acetylsalicylic acid monotherapy in relation to endothelial function in peripheral artery disease, a phase IV clinical trialFRONTIERS IN CARDIOVASCULAR MEDICINE. Bd. 9. 2022
Creeper, Katherine J.; Cohen, Alexander T.; Alikhan, Raza et al.
Early Time Courses of Recurrent Thromboembolism and Bleeding during Apixaban or Dalteparin Therapy for Patients with CancerBLOOD. Bd. 140. 2022 S. 8515-8517
Haghikia, Arash; van Mens, Thijs E.; Pontarollo, Giulia et al.
Editorial: Impact of the gut microbiota on cardiovascular medicineFRONTIERS IN MEDICINE. Bd. 9. 2022
Panova-Noeva, Marina; Falanga, Anna
Editorial: Role of the Platelet Phenomenon in Cardiovascular Diseases and CancerFRONTIERS IN CARDIOVASCULAR MEDICINE. Bd. 9. 2022
Kouz, Karim; Bergholz, Alina; Diener, Oliver et al.
Effect of intraoperative personalized goal-directed hemodynamic management on acute myocardial injury in high-risk patients having major abdominal surgery: a post-hoc secondary analysis of a randomized clinical trialJOURNAL OF CLINICAL MONITORING AND COMPUTING. Bd. 36. H. 6. 2022 S. 1775-1783
Bonaca, Marc P.; Szarek, Michael; Debus, E. Sebastian et al.
Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a "CASPAR like" outcome from VOYAGER PADCLINICAL CARDIOLOGY. Bd. 45. H. 12. 2022 S. 1143-1146